Serotonin News and Research

Latest Serotonin News and Research

Depression treatment helps non-cancer pain patients to stop taking opioids

Opioid cessation in non-cancer pain may be more successful when depression is treated to remission, a Saint Louis University study shows.

5 Feb 2018

Novel grape-derived compounds could be developed as therapeutic agents for treatment of depression

In a study to be published online February 2 in Nature Communications, scientists from the Icahn School of Medicine at Mount Sinai describe an extensive analysis of novel grape-derived compounds, dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc),which might be developed as therapeutic agents for the treatment of depression.

2 Feb 2018

Platelets play more important role in the immune system than previously thought

Platelets play a much more important role in our immune system than previously thought, according to a study published by researchers from Université Laval and Centre hospitalier universitaire de Québec Research Center.

1 Feb 2018

Inhaled carbon dioxide triggers group of neurons responsible for arousal

Breathing too much carbon dioxide can be deadly, but it can happen during sleep if a particular sleeping position causes an obstructed airway or because of a medical condition like sleep apnea.

30 Jan 2018

New molecular research shows how antidepressants work

New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain.

29 Jan 2018

UK-based charity to accelerate development of promising new drug for Parkinson's

UK-based charity, Parkinson's UK is set to provide more than $1million in funding to US biotech company, Neurolixis, to accelerate the development of a promising new drug for people with Parkinson's.

24 Jan 2018

Prebiotics could enhance the learning and memory skills of infants

This news article describes a recent study which showed that learning and memory skills could be enhanced by adding prebiotics to piglet feed.

19 Jan 2018

Study identifies new target for treatment of depression

According to the World Health Organization more than three hundred million people worldwide are affected by major depressive disorder. Unfortunately, the antidepressants commonly used to treat them only work for 50% of the population.

18 Jan 2018

Genetic analysis can enhance outcomes of depression treatment

The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients.

12 Jan 2018

UTA researchers analyze challenges in pain management for the elderly

Researchers at The University of Texas at Arlington are focusing their attention on pain management in older adults, a segment of the population which presents a specific series of challenges to health providers.

20 Dec 2017

Brief test can help determine whether drugs, talk therapy work better for treating anxiety

Clinicians and patients often struggle to find the right treatment for anxiety, sometimes cycling through various therapies for months before the patient begins to feel their symptoms improve.

8 Dec 2017

UA researcher awarded $2.3 million NIH grant to develop new treatments for depression

A University of Arizona College of Medicine-Phoenix researcher has received a $2.3 million grant from the National Institutes of Health to develop new treatments for depression.

7 Dec 2017

Study characterizes effects of opioids on brain proteins other than opioid receptors

In a new study, researchers have characterized the effects of a series of opioids on proteins in the brain other than opioid receptors.

6 Dec 2017

New targeted treatment could benefit patients with certain pancreatic tumors

Researchers at the University of Cincinnati College of Medicine have shown that a new targeted treatment could benefit patients with certain pancreatic tumors by preventing spread of the cancer and protecting their heart from damage--a direct result of the tumor.

1 Dec 2017

Researchers uncover link between abdominal aortic aneurysm and dysregulated tryptophan metabolism

Researchers have found a link between dysregulated tryptophan metabolism and abdominal aortic aneurysm, a life-threatening vascular disease, according to a new study led by Georgia State University.

13 Nov 2017

Scientists develop potential new antidepressant with unique mechanism of action

A potential new antidepressant and antianxiety treatment with a unique mechanism of action has been developed by scientists at the University of Bath.

6 Nov 2017

$Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients$

Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients

Opioids and selective serotonin reuptake inhibitors, a widely used group of antidepressants, are both associated with higher risk of osteoporotic fractures for patients with rheumatoid arthritis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Commonly prescribed medications may not benefit depressed CKD patients

A clinical trial involving hundreds of participants has shown that one of the most frequently prescribed antidepressants may not benefit millions of patients who also have chronic kidney disease (CKD).

3 Nov 2017

Developmental abnormality discovered in babies linked to SIDS

International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).

25 Oct 2017

Serotonin News and Research

Latest Serotonin News and Research

Depression treatment helps non-cancer pain patients to stop taking opioids

Novel grape-derived compounds could be developed as therapeutic agents for treatment of depression

Platelets play more important role in the immune system than previously thought

Inhaled carbon dioxide triggers group of neurons responsible for arousal

New molecular research shows how antidepressants work

UK-based charity to accelerate development of promising new drug for Parkinson's

Prebiotics could enhance the learning and memory skills of infants

Study identifies new target for treatment of depression

Genetic analysis can enhance outcomes of depression treatment

UTA researchers analyze challenges in pain management for the elderly

Brief test can help determine whether drugs, talk therapy work better for treating anxiety

UA researcher awarded $2.3 million NIH grant to develop new treatments for depression

Study characterizes effects of opioids on brain proteins other than opioid receptors

New targeted treatment could benefit patients with certain pancreatic tumors

Researchers uncover link between abdominal aortic aneurysm and dysregulated tryptophan metabolism

Scientists develop potential new antidepressant with unique mechanism of action

Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Commonly prescribed medications may not benefit depressed CKD patients

Developmental abnormality discovered in babies linked to SIDS

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Serotonin News and Research

Latest Serotonin News and Research

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Newsletters you may be interested in